These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32275906)

  • 1. Molecular Profiling of Vascular Remodeling in Chronic Pulmonary Disease.
    Neubert L; Borchert P; Stark H; Hoefer A; Vogel-Claussen J; Warnecke G; Eubel H; Kuenzler P; Kreipe HH; Hoeper MM; Kuehnel M; Jonigk D
    Am J Pathol; 2020 Jul; 190(7):1382-1396. PubMed ID: 32275906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
    Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
    J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic cells and granulysin in pulmonary arterial hypertension and pulmonary veno-occlusive disease.
    Perros F; Cohen-Kaminsky S; Gambaryan N; Girerd B; Raymond N; Klingelschmitt I; Huertas A; Mercier O; Fadel E; Simonneau G; Humbert M; Dorfmüller P; Montani D
    Am J Respir Crit Care Med; 2013 Jan; 187(2):189-96. PubMed ID: 23220918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of medical therapy in pulmonary arterial hypertension. Is there an alternative diagnosis?
    Harch S; Whitford H; McLean C
    Chest; 2009 Jun; 135(6):1462-1469. PubMed ID: 19188548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
    Chaisson NF; Dodson MW; Elliott CG
    Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.
    den Toom ML; Grinwis G; van Suylen RJ; Boroffka SA; de Jong P; van Steenbeek FG; Szatmári V
    Acta Vet Scand; 2018 Dec; 60(1):78. PubMed ID: 30518401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary veno-occlusive disease - a rare form of pulmonary arterial hypertension].
    Halank M; Kolditz M; Langner S; Höffken G
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S212-4. PubMed ID: 18814100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease.
    Seferian A; Helal B; Jaïs X; Girerd B; Price LC; Günther S; Savale L; Dorfmüller P; Parent F; Sitbon O; Humbert M; Simonneau G; Montani D
    Eur Respir J; 2012 Jul; 40(1):75-83. PubMed ID: 22088969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.
    Ogawa A; Takahashi Y; Matsubara H
    J Cardiol; 2018 Sep; 72(3):255-260. PubMed ID: 29548663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
    Lai YJ; Chen PR; Huang YL; Hsu HH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension.
    Connolly MJ; Abdullah S; Ridout DA; Schreiber BE; Haddock JA; Coghlan JG
    Rheumatology (Oxford); 2017 Dec; 56(12):2197-2203. PubMed ID: 29029203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D
    Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences.
    Montani D; Kemp K; Dorfmuller P; Sitbon O; Simonneau G; Humbert M
    Semin Respir Crit Care Med; 2009 Aug; 30(4):411-20. PubMed ID: 19634080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary veno-occlusive disease.
    Iwaki M; Imaizumi K; Yokoi T; Kondo M; Kawaguchi K; Hasegawa Y
    Intern Med; 2009; 48(15):1289-92. PubMed ID: 19652432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature .
    Daraban AM; Enache R; Predescu L; Platon P; Constantinescu T; Mihai C; Coman IM; Ginghina C; Jurcuţ R
    Rom J Intern Med; 2015; 53(2):175-83. PubMed ID: 26402988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension].
    Karakurt Z
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():63-8. PubMed ID: 20819769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.
    Lederer H; Muggli B; Speich R; Treder U; Stricker H; Goede J; Ulrich S; Stämpfli SF; Breitenstein A
    PLoS One; 2014; 9(12):e115219. PubMed ID: 25501010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
    Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
    Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.